✦ LIBER ✦

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

✍ Scribed by D.J. Winston; D. Wirin; A. Shaked; R.W. Busuttil

Book ID: 118559135
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 876 KB
Volume: 346
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)92110-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of higher dose and lower dose

Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients

✍ S.-O. Lee; J.H. Rim; H. Sung; S.-H. Kim; S.-H. Choi; C.W. Lee; T.J. Yun; J.-W. L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Oral ganciclovir versus valganciclovir f

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

✍ R.L. Brady; K. Green; C. Frei; P. Maxwell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

A comparative randomised study of valacy

A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients

✍ I. D. Pavlopoulou; V. Ph. Syriopoulou; H. Chelioti; G. L. Daikos; D. Stamatiades 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Randomized controlled trial of oral ganc

Randomized controlled trial of oral ganciclovir versus intravenous ganciclovir for long-term prophylaxis of cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients willi CMV-seropositive donors

✍ D. Winston; R.W. Busuttil 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A Study of the Pharmacokinetic Profile o

A Study of the Pharmacokinetic Profile of Low-Dose Hepatitis B Immune Globulin in Long-Term Liver Transplant Recipients for Chronic Hepatitis B Infection

✍ Nilufar Partovi; Michelle W. Guy; Mary H. H. Ensom; Michael A. Noble; Eric M. Yo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB